1. Introduction

Palliative care aims to relieve distressing symptoms—especially pain—so patients with life-limiting illnesses can have the best possible quality of life. Morphine remains the gold-standard strong opioid for moderate to severe pain. Effective morphine prescribing in palliative care involves:

• Background (regular) dosing for continuous pain control
• Breakthrough (PRN) dosing for sudden pain flares
• Systematic dose adjustments based on patient response and PRN usage

Additionally, morphine can help alleviate dyspnea (breathlessness). However, when prescribing morphine for dyspnea alone (without pain), a lower dose is often sufficient—typically half the dose used for pain.

2. IPD vs. OPD Approaches

In-Patient Department (IPD)

• Close monitoring is possible (vital signs, sedation, respiratory rate).
• Dose titration can be faster (e.g., adjusting every 24 hours or even more frequently).
• Both Method 1 (percentage-based increase) and Method 2 (adding PRN to baseline) are practical because the patient is under direct observation.

Out-Patient Department (OPD)

• Monitoring is less frequent; safety and simplicity are crucial.
• Start with a more cautious dose and titrate more slowly.
• Clear written instructions for adjusting doses at home are vital—often with scheduled follow-ups or phone consults.

3. Comprehensive Pain Assessment

A thorough assessment underpins effective morphine use:

1. Pain Character: Aching, burning, stabbing, etc.
2. Severity: Use a pain scale (0–10 or mild/moderate/severe).
3. Pattern: Persistent vs. episodic flares.
4. Functional Impact: Effect on daily activities, sleep, and mood.

Holistic evaluation of psychological, social, and spiritual factors is also essential.

4. Setting Up Morphine Background Orders

For persistent pain, two key strategies help refine the dose:

4.1 Starting Dose: 30 mg/24h (Pain)

For opioid-naïve adults with moderate to severe pain, a commonly cited oral morphine starting point is:

• 30 mg/24h total (e.g., 5 mg every 4 hours)
  • This may also be given as an extended-release formulation 15 mg every 12 hours (totaling 30 mg per day).

Starting low and going slow helps reduce the risk of opioid-related side effects (e.g., sedation, respiratory depression). If this dose is well-tolerated but pain is not controlled, subsequent titration is necessary.

Note: Older or very frail patients may need an even lower starting dose (e.g., 2.5 mg every 4 hours).

4.2 Starting Dose for Dyspnea Only: 15 mg/24h

If morphine is used for dyspnea (breathlessness) without significant pain, the initial total daily dose can often be half the typical pain dose—about 15 mg/24h (e.g., 2.5 mg every 4 hours). Clinical judgment and patient factors (age, comorbidities) guide this decision.

5. Titration Methods

Once a patient is established on a background dose, two key methods guide ongoing dose adjustments:

5.1 Method 1: Percentage-Based Increase

• Assess Pain and Side Effects: After 24–48 hours on a stable morphine regimen.
• Dose Increase: If pain remains uncontrolled, increase the total daily dose by 25–50%.
  • Example: If a patient is on 60 mg/day and has persistent moderate-to-severe pain, increase to ~75–90 mg/day.
• Monitor: Reassess pain scores, sedation level, and adverse effects.

This approach is straightforward and commonly used when precise tracking of PRN usage is challenging.

5.2 Method 2: Add the Previous Day’s PRN Total

• Track PRN Usage: Record all breakthrough morphine doses used in 24 hours.
• Add PRN Total to Background: The next day’s background dose = current daily dose + total PRN amount from the previous 24 hours.
  • Example:
    • Day 1 Background Dose = 60 mg/24h
    • Day 1 PRN Usage = 20 mg total
    • New Background Dose (Day 2) = 60 mg + 20 mg = 80 mg/24h

This method tailors the background dose to real-life opioid requirements.

6. Regular (Around-the-Clock) Dosing

• Continuous Pain Relief: Around-the-clock morphine ensures persistent baseline pain is consistently managed.
• Long-Acting/Extended-Release: May be given every 12 hours (e.g., morphine sulfate SR) or every 24 hours depending on the product and patient tolerance.

In an IPD setting, short-acting q4h dosing is common initially (especially if rapid titration is needed). In the OPD setting, extended-release preparations may be more convenient once the correct total daily dose is established.

7. Breakthrough Pain (BTP) Management

Breakthrough pain is a sudden flare of pain that breaks through well-controlled baseline pain.

• Immediate-Release Morphine (PRN): Often 10–20% of the total 24-hour morphine background dose.
  • Example: If total daily dose is 60 mg, the PRN would be ~6–12 mg every 30–60 minutes as needed.
• Reassessment: If breakthrough doses are used more than 3–4 times in 24 hours, increase the background dose using either Method 1 or Method 2.

8. WHO Analgesic Ladder & Adjuncts

1. Step 1: Non-opioids (paracetamol, NSAIDs)
2. Step 2: Weak opioids (codeine, tramadol)
3. Step 3: Strong opioids (morphine, fentanyl, oxycodone)

Adjuvant therapies (e.g., antidepressants, anticonvulsants, corticosteroids) may be added at any step for neuropathic or inflammatory pain components.

9. Common Opioid Conversions

10. Side Effect Management

Opioid Side Effects

• Sedation
• Nausea/vomiting
• Constipation
• Respiratory depression
• Itching
• Urinary retention

Preventive Strategies

• Bowel Regimen (e.g., senna, lactulose) to prevent constipation.
• Antiemetics (e.g., metoclopramide, haloperidol) for nausea.
• Opioid Rotation if side effects are severe or analgesia remains poor after appropriate titration.

11. Putting It All Together: Case Example

Patient Scenario (Pain):

• 70-year-old with advanced cancer, opioid-naïve, moderate to severe pain.
• Start with 30 mg/24h oral morphine (e.g., 5 mg q4h).
• PRN dose: ~10–20% of total daily dose → ~3–6 mg as needed.

Day 1

• Background dose: 30 mg/24h
• Breakthrough usage: Suppose the patient needs 3 extra doses of 5 mg each = 15 mg total in 24 hours.

Dose Adjustment

• Method 1: Increase by 25–50% → 30 mg + (25–50% of 30 mg) = 38–45 mg/24h.
• Method 2: Add PRN total → 30 mg + 15 mg = 45 mg/24h.

Choose the appropriate new total, and recalculate the PRN dose (10–20% of new total). Continue close monitoring, especially in IPD (daily reassessment). In OPD, ensure follow-up for ongoing dose adjustments.

Dyspnea Example (No Significant Pain)

• Patient with COPD and severe breathlessness, no major pain.
• Start at 15 mg/24h (e.g., 2.5 mg q4h) + small PRN doses for breakthrough dyspnea.
• Titrate slowly, watching for sedation or respiratory depression, especially in OPD settings.

12. Key Takeaways

1. IPD vs. OPD: Inpatient settings allow faster titration with close monitoring; outpatient settings require more cautious steps and thorough patient/caregiver education.
2. Start Low, Go Slow: Common starting morphine dose for moderate-severe pain is ~30 mg/24h (oral), or half that (15 mg/24h) for dyspnea without pain.
3. Scheduled (ATC) + PRN: Ensure continuous control of baseline pain/dyspnea while addressing flares.
4. Two Titration Methods:
   • Method 1: Increase daily dose by 25–50% based on pain control.
   • Method 2: Add the previous 24-hour PRN total to the next day’s baseline.
5. Holistic Assessment: Look beyond physical symptoms; address emotional, social, and spiritual needs.
6. Side Effects: Prevent and manage with laxatives, antiemetics, and close monitoring.
7. Ongoing Monitoring: Pain scores, sedation, respiratory rate, bowel function—all guide safe and effective morphine use.